Tony Butler
Stock Analyst at Rodman & Renshaw
(0.94)
# 3,705
Out of 4,868 analysts
105
Total ratings
31.37%
Success rate
-13.92%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tony Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATRA Atara Biotherapeutics | Initiates: Buy | $25 | $8.02 | +211.72% | 2 | Dec 20, 2024 | |
| HURA TuHURA Biosciences | Initiates: Buy | $11 | $2.70 | +307.41% | 1 | Dec 19, 2024 | |
| BMEA Biomea Fusion | Upgrades: Buy | $18 | $1.91 | +842.41% | 4 | Sep 26, 2024 | |
| MURA Mural Oncology | Initiates: Buy | $15 | $2.47 | +507.29% | 1 | Jun 28, 2024 | |
| LPTX Leap Therapeutics | Initiates: Buy | $8 | $0.39 | +1,949.18% | 1 | Jun 28, 2024 | |
| IPSC Century Therapeutics | Reiterates: Buy | $16 | $0.59 | +2,628.51% | 5 | Aug 10, 2023 | |
| ADAP Adaptimmune Therapeutics | Reiterates: Buy | $10 | $0.26 | +3,806.25% | 8 | Aug 10, 2023 | |
| FATE Fate Therapeutics | Reiterates: Buy | $10 | $1.21 | +726.45% | 4 | Aug 9, 2023 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $75 | $44.43 | +68.80% | 8 | Aug 8, 2023 | |
| MRUS Merus | Reiterates: Buy | $35 | $52.59 | -33.45% | 7 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $60 | $2.90 | +1,968.97% | 5 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $1.66 | +685.50% | 6 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $50 | $7.41 | +574.76% | 5 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.29 | +1,062.79% | 8 | Aug 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $0.40 | +6,173.53% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $1.14 | +1,215.79% | 1 | Jul 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.29 | +336.68% | 3 | Jul 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $1.70 | +900.00% | 2 | Jul 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8.3 → $166 | $4.47 | +3,613.65% | 4 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $9.49 | +532.24% | 4 | Jun 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $240 | $2.13 | +11,167.61% | 4 | Jun 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $0.67 | +793.92% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $360 | $4.86 | +7,307.41% | 1 | Jun 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $5 → $2 | $3.05 | -34.43% | 6 | May 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $3.11 | +382.32% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $30 → $10 | $1.47 | +580.27% | 2 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $15 | $2.38 | +530.25% | 1 | Nov 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $110 | $9.60 | +1,045.83% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $0.45 | +17,575.65% | 1 | Mar 2, 2020 |
Atara Biotherapeutics
Dec 20, 2024
Initiates: Buy
Price Target: $25
Current: $8.02
Upside: +211.72%
TuHURA Biosciences
Dec 19, 2024
Initiates: Buy
Price Target: $11
Current: $2.70
Upside: +307.41%
Biomea Fusion
Sep 26, 2024
Upgrades: Buy
Price Target: $18
Current: $1.91
Upside: +842.41%
Mural Oncology
Jun 28, 2024
Initiates: Buy
Price Target: $15
Current: $2.47
Upside: +507.29%
Leap Therapeutics
Jun 28, 2024
Initiates: Buy
Price Target: $8
Current: $0.39
Upside: +1,949.18%
Century Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $16
Current: $0.59
Upside: +2,628.51%
Adaptimmune Therapeutics
Aug 10, 2023
Reiterates: Buy
Price Target: $10
Current: $0.26
Upside: +3,806.25%
Fate Therapeutics
Aug 9, 2023
Reiterates: Buy
Price Target: $10
Current: $1.21
Upside: +726.45%
CRISPR Therapeutics AG
Aug 8, 2023
Reiterates: Buy
Price Target: $75
Current: $44.43
Upside: +68.80%
Merus
Aug 8, 2023
Reiterates: Buy
Price Target: $35
Current: $52.59
Upside: -33.45%
Aug 7, 2023
Reiterates: Hold
Price Target: $60
Current: $2.90
Upside: +1,968.97%
Aug 7, 2023
Reiterates: Buy
Price Target: $13
Current: $1.66
Upside: +685.50%
Aug 3, 2023
Reiterates: Buy
Price Target: $50
Current: $7.41
Upside: +574.76%
Aug 3, 2023
Reiterates: Buy
Price Target: $15
Current: $1.29
Upside: +1,062.79%
Aug 2, 2023
Reiterates: Buy
Price Target: $25
Current: $0.40
Upside: +6,173.53%
Jul 31, 2023
Initiates: Buy
Price Target: $15
Current: $1.14
Upside: +1,215.79%
Jul 12, 2023
Reiterates: Buy
Price Target: $10
Current: $2.29
Upside: +336.68%
Jul 7, 2023
Reiterates: Buy
Price Target: $17
Current: $1.70
Upside: +900.00%
Jul 3, 2023
Reiterates: Buy
Price Target: $8.3 → $166
Current: $4.47
Upside: +3,613.65%
Jun 7, 2023
Reiterates: Buy
Price Target: $60
Current: $9.49
Upside: +532.24%
Jun 5, 2023
Reiterates: Buy
Price Target: $240
Current: $2.13
Upside: +11,167.61%
Jun 1, 2023
Assumes: Buy
Price Target: $6
Current: $0.67
Upside: +793.92%
Jun 1, 2023
Assumes: Buy
Price Target: $360
Current: $4.86
Upside: +7,307.41%
May 30, 2023
Maintains: Hold
Price Target: $5 → $2
Current: $3.05
Upside: -34.43%
Jan 5, 2023
Initiates: Buy
Price Target: $15
Current: $3.11
Upside: +382.32%
Feb 17, 2022
Downgrades: Neutral
Price Target: $30 → $10
Current: $1.47
Upside: +580.27%
Nov 19, 2021
Initiates: Buy
Price Target: $15
Current: $2.38
Upside: +530.25%
Jun 28, 2021
Maintains: Buy
Price Target: $80 → $110
Current: $9.60
Upside: +1,045.83%
Mar 2, 2020
Initiates: Buy
Price Target: $80
Current: $0.45
Upside: +17,575.65%